United States · FDA National Drug Code directory
Doxepin hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72205-052_da77c05e-0081-4f48-b3cf-2a378739a968
- Product NDC
- 72205-052
- Form
- TABLET
- Composition / generic term
- Doxepin hydrochloride
- Labeler
- Novadoz Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230403
- Source listing expiry
- 20271231
Source-listed ingredients
- DOXEPIN HYDROCHLORIDE — 3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (72205-052-05) · 72205-052-05
- 30 TABLET in 1 BOTTLE (72205-052-30) · 72205-052-30
- 100 TABLET in 1 BOTTLE (72205-052-91) · 72205-052-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →